Interstitial lung diseases
Symposium
Human ex vivo models of interstitial lung disease
Basic science
Aims : To present models of early events of idiopathic pulmonary fibrosis (IPF) ex vivo and the use of these models in evaluating pathogenesis and treatment; and to evaluate the potential use of lung organoids for drug screening.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, Medical Student, Physician in Pulmonary Training, Scientist (basic, translational)
Methods :
Cell and molecular biology
18:00
Introduction
1
4832
18:05
3D tissue culture to study the mechanisms of lung repair in IPF
M. Konigshoff(Pittsburgh, United States)
COI
-
Description
2
4833
18:15
Using induced pluripotent stem cells to study the type II pneumocyte
K. Hurley(Co. Meath, Ireland)
COI
-
Description
3
4834
18:25
Lung-on-a -chip: state of the art
N. Roldan(Stuttgart, Germany)
COI
-
Description
4
4835
18:35
The role of cell lines in modelling the type II pneumocyte in interstitial lung disease
J. Dickens(Cambridge (Cambridgeshire), United Kingdom)
COI
5
4836
18:45
Discussion and Q&A
6
4837
. . .